The Acute Stroke Unit at the University Hospitals Dorset has recently seen a million pound upgrade of its stroke services, as part of a wider regional healthcare plan. This establishes Royal Bournemouth Hospital as the major emergency hospital in the area, offering flexibility, patient care streamlining and efficiency to the region.

This consolidation offers more patients access to its state-of-the-art facilities including the Lokomat, an electromechanical gait trainer which helps stroke patients relearn how to walk. University Hospitals Dorset NHS Charity successfully fundraised to purchase the Lokomat as part of their award-winning “Walkerbot Campaign” back in 2021, and the Lokomat is making a big difference to the treatment of patients on the unit.

Watch the article now on ITV News.

About the Lokomat

Relearn how to walk again with the Lokomat, a robotic rehabilitation device which enables intensive gait training for severely impaired patients – even those who can’t move their lower limbs at all.

Patients can complete hundreds or even thousands of steps per session, compared to traditional manual physiotherapy.

The Lokomat is developed by Hocoma and provided in the UK by Summit Medical and Scientific.

Read more about the Lokomat.

About Summit Medical and Scientific

Summit Medical and Scientific are passionate about the power of rehabilitation technology.

We represent clinical technology leaders Hocoma, Motek, Life Science Robotics and ddrobotec® to provide the total solution for rehabilitation in the UK. Our partners have developed innovative therapy devices using robotics, sensors and virtual reality for early and acute rehabilitation, gait and balance therapy, arm and hand therapy, body weight support and more. View all of our clinical solutions here.

Get in touch with Summit Medical and Scientific today to find out more about incorporating state-of-the-art rehabilitation technology into your practice. You can reach out via email at info@summitmedsci.co.uk or phone 01372 459863.

You can also follow us on Facebook, InstagramTwitter and LinkedIn, and subscribe to our newsletter for the latest updates.